Market Cap ₹37 Cr.
Stock P/E 12.3
P/B 1.6
Current Price ₹77.7
Book Value ₹ 49.5
Face Value 10
52W High ₹299.3
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|
Net Sales | 0 | 2 | 5 | 21 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 0 | 3 | 5 | 22 | |
Total Expenditure | 0 | 2 | 4 | 18 | |
Operating Profit | -0 | 1 | 1 | 4 | |
Interest | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | -0 | 1 | 1 | 4 | |
Provision for Tax | 0 | 0 | 0 | 1 | |
Profit After Tax | -0 | 1 | 1 | 3 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | -0 | 1 | 1 | 3 | |
Adjusted Earnings Per Share | -0.4 | 1.7 | 2.3 | 8.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 320% | 0% | 0% | 0% |
Operating Profit CAGR | 300% | 0% | 0% | 0% |
PAT CAGR | 200% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 143% | 179% | 135% | 135% |
ROCE Average | 192% | 172% | 129% | 129% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Shareholder's Funds | -1 | -0 | 1 | 4 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | -0 | 0 | 0 | 0 |
Total Current Liabilities | 3 | 2 | 19 | 5 |
Total Liabilities | 2 | 1 | 20 | 9 |
Fixed Assets | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 1 | 1 | 0 | 0 |
Total Current Assets | 2 | 1 | 20 | 8 |
Total Assets | 2 | 1 | 20 | 9 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 4 |
Cash Flow from Operating Activities | 0 | 0 | 4 | -4 |
Cash Flow from Investing Activities | 0 | 0 | -0 | -0 |
Cash Flow from Financing Activities | -0 | -0 | -0 | 0 |
Net Cash Inflow / Outflow | 0 | -0 | 4 | -4 |
Closing Cash & Cash Equivalent | 0 | 0 | 4 | 0 |
# | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Earnings Per Share (Rs) | -0.38 | 1.68 | 2.29 | 8.75 |
CEPS(Rs) | -0.37 | 1.68 | 2.29 | 8.76 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -2.25 | -0.56 | 1.72 | 10.47 |
Core EBITDA Margin(%) | -59.85 | 25.02 | 18.7 | 16.84 |
EBIT Margin(%) | -28.54 | 27.4 | 21.61 | 18.85 |
Pre Tax Margin(%) | -144.47 | 23.46 | 21.14 | 18.85 |
PAT Margin (%) | -144.47 | 23.46 | 15.1 | 14.11 |
Cash Profit Margin (%) | -142.48 | 23.51 | 15.12 | 14.13 |
ROA(%) | -5.98 | 32.03 | 7.36 | 21.17 |
ROE(%) | 0 | 0 | 394.75 | 143.48 |
ROCE(%) | -1.25 | 58.45 | 266.44 | 191.74 |
Receivable days | 0 | 0 | 0 | 0 |
Inventory Days | 6406.48 | 183.2 | 580.17 | 203.3 |
Payable days | 477.92 | 123.87 | 877.96 | 235.03 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 32.88 | 0.24 | -0.7 | 0.16 |
EV/Core EBITDA(x) | -123.87 | 0.86 | -3.23 | 0.84 |
Net Sales Growth(%) | 0 | 2633.85 | 111.5 | 309.4 |
EBIT Growth(%) | 0 | 2724.42 | 66.84 | 257.11 |
PAT Growth(%) | 0 | 543.95 | 36.13 | 282.47 |
EPS Growth(%) | 0 | 543.95 | 36.13 | 282.47 |
Debt/Equity(x) | -3.66 | -2.3 | 0 | 0 |
Current Ratio(x) | 0.57 | 0.57 | 1.03 | 1.73 |
Quick Ratio(x) | 0.03 | 0.02 | 0.22 | 0.08 |
Interest Cover(x) | -0.25 | 6.97 | 45.74 | 0 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|
Promoter | 72.03 | 72.03 | 72.03 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 27.97 | 27.97 | 27.97 |
Others | 0 | 0 | 0 |
Total | 100 | 100 | 100 |
# | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|
Promoter | 0.35 | 0.35 | 0.35 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 0.13 | 0.13 | 0.13 |
Others | 0 | 0 | 0 |
Total | 0.48 | 0.48 | 0.48 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About